Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

NCT00003827 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: amifostine trihydrate
DRUG: cytarabine
DRUG: topotecan hydrochloride

Sponsor

ALZA